Stocks to buy

As the stock market rally continues, the trillion-dollar market cap club stands to get just a bit more crowded. Undoubtedly, more than a handful of mega-cap titans could pass the $1 trillion milestone as soon as 2024. And many of the top plays don’t need to skyrocket by an absurd amount to accomplish the feat.

The world revolves around money. People use it as a medium of exchange to buy goods and services. Various middlemen make money from financial transactions, and other companies offer resources that can improve your finances. These corporations fit within the fintech umbrella. Stocks in this industry often have millions of customers who use their loans,

The healthcare industry is experiencing extraordinary rapid terrain evolution as advancement meets necessity. Investors are focusing on disruptive businesses during this wave of change. These companies have the potential to transform the industry and provide exceptional returns. The edge of innovation and technology transcends the limits of traditional care, making healthcare more than just a

Graphics chip and CPU designer Advanced Micro Devices (NASDAQ:AMD) stock has had a tough several days. The chipmaker’s share price has fallen nearly 10% in the past week. Most recently, China’s government announced a ban on Intel (NASDAQ:INTC) and AMD chips from government computers, fanning flames to the “tech war” between the United States and

Wall Street just can’t keep up with Nvidia (NASDAQ:NVDA) stock. As soon as analysts raise their price target on the artificial intelligence (AI) chipmaker, it blows past through their threshold on its way to new highs. Always playing catch up, Wall Street then raises their targets again. In March alone, 15 analysts raised their target

We all want to find those elusive hypergrowth stocks that can deliver eye-popping returns year after year. Who wouldn’t love doubling their money on an annual basis? While that kind of performance is rare, some hypergrowth stocks do offer that tantalizing potential. These fast-growing companies can quickly become multibaggers for investors with the patience and

Like every other publicly listed business, enterprise artificial intelligence company C3.ai (NYSE:AI) has room to improve. If we look closely, we can find some financial imperfections with C3.ai, but don’t lose faith in the company. As long as the demand for AI-related products continues to grow, investors should hang on to AI stock. C3.ai CEO Tom

The small-cap space provides some exciting opportunities for robust returns in quick time. Further, some quality small-cap stock rallies are backed by fundamentals and positive business catalysts. This column discusses three small-cap stocks for 100% returns before the end of the year. Like always, I have steered clear of purely speculative ideas. The businesses discussed

Dividends are a key part of the total return equation. Indeed, adding some of the best dividend stocks to buy can boost your portfolio returns. At the same time, it can lower your overall portfolio volatility. According to Fidelity, since 1930, dividends have accounted for 40% of the S&P 500’s total return. Even better, the

The demand for better environmental tech and solutions continues to ramp up as we tread the path toward a greener world. Due to this, several sectors have reached new pinnacles. However, this growth isn’t the same for each market. One of these lagging markets is hydrogen, which is why some investors are hunting for the

With so many different companies claiming the artificial intelligence (AI) moniker as of late, it can be difficult to determine which AI offerings are worth investing in. Companies can define themselves as AI stocks by doing anything from providing cloud infrastructure hardware to training large language models to using machine learning for data analysis. To

The tech sector has been a solid industry for outperforming the market. The S&P 500 and the Nasdaq 100 both have most of their assets allocated toward the information technology sector. Six of the Magnificent Seven stocks are in the tech sector. Non-tech companies like Tesla (NASDAQ:TSLA) have been branded as tech companies to make them more

After years of stagnation, cannabis stocks to buy are back on the menu. A range of bullish factors sent the sector surging over the past few weeks, with popular cannabis ETF Amplify Alternative Harvest ETF (NYSEARCA:MJ) jumping 10% in the past 5 days alone and 25% since January 1st. Of course, not all cannabis stocks

Software stocks permeate today’s market, and the trend is here to stay. Democratized, no-code platforms make software startups a breeze, and many of these founders (and investors) have their sights on liquidity events that end with the company listed on public exchanges. For investors, though, that represents a challenge. Differentiation is key in software sectors,

Investing in the long term is one of the best ways to become proficient as a trader, in my opinion. It can be difficult at times because investors want to immediately experience impressive returns from investments, which can lead to making irrational decisions that may lead to unnecessary losses. It isn’t the most flashy method

This month in March is a great time to pick up shares in these best penny stocks to buy. I chose the companies due to their strong fundamentals and potential for significant upside. Investing in penny stocks can provide the opportunity for substantial returns, as these lower-priced shares have more room for capital appreciation compared

A constellation of stocks beckons daring investors from the great expanse of the financial galaxy, where stars glitter with promise and fortunes wait to be discovered. The first stop on the journey is a celestial body whose excellent recovery rates and record-breaking throughput suggest a gold mine of opportunities. Travelers discover the keys of management

There is no substitute for dividend stocks when it comes to making money on Wall Street. Studies show dividend payers significantly outperform stocks that don’t reward shareholders and do so with less risk. Dividends are also responsible for the lion’s share of the stock market’s long-term performance. Ned Davis Research found income-generating stocks represented 41%

U.S. stocks have logged sizable gains in recent months, registering a 30% gain since October last year. Some analysts are starting to worry that the market may be reaching overbought levels and is due for a correction. While growth stocks have propelled the market, their rapid growth also means deeper potential declines if prices turn

One of the best dip-buying opportunities in biotech stocks to buy was in Viking Therapeutics (NASDAQ:VKTX). After hitting a high of $99.41, VKTX dipped back to about $60.30. All because of obesity data from a competitor. But that pullback wouldn’t last long. In fact, by March 26, the stock soared more than $12 a share on